The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure.
about
Correlation between brain natriuretic peptide levels and the prognosis of patients with left ventricular diastolic dysfunctionLiver stiffness: a novel parameter for the diagnosis of liver disease.[Biomarker for diagnosis of rejection after heart transplantation].Prognostic value of brain natriuretic peptide in patients with heart failure and reserved left ventricular systolic function.Cardiac indexes, cardiac damage biomarkers and energy expenditure in professional cyclists during the Giro d'Italia 3-weeks stage race.Improved LFIAs for highly sensitive detection of BNP at point-of-careAortic stiffness as a marker of cardiac function and myocardial strain in patients undergoing aortic valve replacementTriiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure.Pathophysiological and clinical relevance of circulating levels of cardiac natriuretic hormones: are they merely markers of cardiac disease?Dynamics of the liver stiffness value using transient elastography during the perioperative period in patients with valvular heart disease.The increasing impact of laboratory medicine on clinical cardiology.Can natriuretic peptides be used for the diagnosis of diastolic heart failure?Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension.BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases.Effects of lesion complexity on baseline and postprocedural B-type natriuretic peptide levels in patients undergoing percutaneous coronary interventions.Monitoring of patients with heart failure.Exercise testing in adults after repair of aortic coarctation: evaluation of cardiopulmonary exercise capacity and B-type natriuretic protein levels.Clinical value of plasma B-type natriuretic peptide assay in pediatric pneumonia accompanied by heart failureHyperthyroidism affects arterial stiffness, plasma NT-pro-B-type natriuretic peptide levels, and subendocardial perfusion in patients with Graves' disease.N-terminal pro B-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patientsThe time-course changes of NT-proBNP and tissue Doppler indices in patients undergoing mitral valve replacement.N-terminal pro b-type natriuretic peptide (NT-pro-BNP) -based score can predict in-hospital mortality in patients with heart failure.Exercise training improves cardiac function and attenuates arrhythmia in CPVT miceN-terminal pro-B-type natriuretic peptide as a marker of disease severity in patients with pericardial effusionsBiochemistry of B-type natriuretic peptide--where are we now?PAPP-A: a marker of plaque instability. Is it ready for prime time?Mechanisms involved in increased plasma brain natriuretic peptide after heart transplantation.Review on natriuretic peptides: where we are, where we are going.Brain natriuretic peptide and right heart dysfunction after heart transplantation.Prognostic Value of Serial N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients With Acute Myocardial Infarction.Dynamic detection of N-terminal pro-B-type natriuretic peptide helps to predict the outcome of patients with major trauma.The prognostic value of atrial and brain natriuretic peptides, troponin I and C-reactive protein in patients with sepsis.Cilostazol attenuates ventricular arrhythmia induction and improves defibrillation efficacy in swine.Perinatal changes of circulating N-terminal pro B-type natriuretic peptide (NT-proBNP) in normal and intrauterine-growth-restricted pregnancies.Serial measurements of N-terminal pro-brain natriuretic peptide after acute ischemic stroke.Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure.Multicenter analytical performance evaluation of the Elecsys proBNP assay.NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis.N-terminal pro-brain natriuretic peptide (NT-proBNP) serum concentrations in apparently healthy Bosnian women.
P2860
Q28601952-D158B843-96EE-476A-9304-03E2B4840487Q30445527-AA9F3000-1BDC-47B2-9060-E0B83B7B3AA2Q33530170-1DCE8CF7-03EB-47E8-8CAE-4E17D164FAE0Q33706264-67FE55D3-97E0-4C4A-85D7-497EADD99DD8Q33773211-9DA1A9C3-F8E5-4201-82DA-E3F6C2CCEBC2Q33820936-EE3BDCBB-470A-41E0-8CA4-935A102B93EEQ33824641-69AEBD17-F431-4494-BD70-A5521070D811Q34190826-CAB979B6-EC10-4C23-BBE3-DC1239A89E1BQ34976750-4B8C53E5-AD54-4FAF-BF4C-4D4C41313CB3Q35132121-015FE384-90AE-4EB5-A0EB-C58DA6A6F808Q35206514-D50C378F-3F10-41D9-B2A9-A85287408830Q35677306-44C7CA73-017B-43BB-BB2B-DAAD86BC1183Q35928009-7A14D879-070A-4361-BC52-02A2A5601A03Q35968889-BCEC3815-18AF-48E9-9E43-8FF37971769FQ35987052-7C53CC4C-DBCC-40AE-91FC-E45B62FB6337Q36015470-886BBFCC-A4E6-424A-B220-7BFF01A0E935Q36236505-780EAAA7-721B-434D-A053-FF4FC183F745Q36319305-B8B379A7-5019-46D2-AC83-A28D239546B3Q36334557-DC5AF9C3-99C7-4D05-8AF9-1D22D89636A6Q36939408-B5E71241-F5FC-493F-B7AD-5C55F5722922Q37040910-F61D67FC-1736-46CA-841A-8A6FA49E9D9BQ37041902-7748ED9B-F2B7-4C99-815E-A554A60E5826Q37093167-598EE8B1-4CAA-4F73-A0FB-F46DC8BD7684Q37174127-5C9692F2-38E3-4E8C-8321-57C093176128Q37203628-56B5DA77-8D6B-467F-A493-E96B9D7982D9Q37289418-20A1A444-36ED-46FE-A9E5-A8DD4056E06BQ37608515-19FDE898-DF83-43F2-B7DF-EB62F90E83ADQ37801768-B84AE580-D9FB-4730-856B-277FA484B647Q38089931-07D19DA2-EACC-4F7A-8A8F-EFA48E871E30Q38897414-92EA6CE6-192B-4204-B74D-58FAD21262B0Q40165610-1B9B522E-B725-49D7-96E6-A78043A5523BQ41188755-2343D8B4-B965-4421-A296-8E6D1E66857EQ41777501-4C6B2CBD-3B4F-4F40-AF06-2D039B86DAA3Q43016274-748948AE-0484-47C0-A017-29C5FC1D502CQ44237599-89B69B3D-B1AA-456C-8147-30D9BC3BF22CQ44241798-8FD8D089-E230-4F12-8D6D-0A2921C816CCQ44983088-67FE86C8-E303-4D27-98AD-E49CB92C0F84Q45074456-D95E2B83-5433-403F-A112-F5DC09FB2DC8Q46678287-F92F3377-7DC9-4679-9D1A-D5A38F738293Q46881773-6CDC0321-91C0-4E87-AE5E-6005530A11A0
P2860
The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The impact of cardiac natriure ...... d management of heart failure.
@ast
The impact of cardiac natriure ...... d management of heart failure.
@en
The impact of cardiac natriure ...... d management of heart failure.
@nl
type
label
The impact of cardiac natriure ...... d management of heart failure.
@ast
The impact of cardiac natriure ...... d management of heart failure.
@en
The impact of cardiac natriure ...... d management of heart failure.
@nl
prefLabel
The impact of cardiac natriure ...... d management of heart failure.
@ast
The impact of cardiac natriure ...... d management of heart failure.
@en
The impact of cardiac natriure ...... d management of heart failure.
@nl
P2093
P2860
P356
P1476
The impact of cardiac natriure ...... d management of heart failure.
@en
P2093
A Hammerer-Lercher
B Puschendorf
P2860
P304
P356
10.1515/CCLM.2001.093
P577
2001-07-01T00:00:00Z